Prediction of B- and T-cell epitopes using in-silico approaches: a solution to the development of recombinant vaccines against COVID-19-Reference-Cited by-同舟云学术

Prediction of B- and T-cell epitopes using in-silico approaches: a solution to the development of recombinant vaccines against COVID-19

Published:2021-03 Issue:1 Volume:33 Page:
ISSN:2724-542X
Container-title:Minerva Biotechnology and Biomolecular Research
language:
Short-container-title:Minerva Biotechnol Biomol Res

Author:

DARIUSHNEJAD Hassan,GHORBANZADEH Vajihe,HASHEMZADEH Pejman

Publisher

Edizioni Minerva Medica

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://www.minervamedica.it/pdf.php?cod=R04Y2021N01A0036

Reference45 articles.

1. Molecular phylogenetics: state-of-the-art methods for looking into the past

2. Immunoinformatics and epitope prediction in the age of genomic medicine

3. A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach;Rehman HM;Preprints,2020

4. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

5. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoinformatics analysis of Brucella melitensis to approach a suitable vaccine against brucellosis;Journal of Genetic Engineering and Biotechnology;2023-12

2. Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: an update;Minerva Medica;2023-11

3. Bioinformatics Analysis to Designing a Multi-epitope-based Peptide Vaccine Combat Leishmania major;Iranian Journal of Medical Microbiology;2022-09-01

4. COVID vaccine's hot problems: erratic serious blood clotting, ill-defined prion-like reactogenicity of the spike, unclear roles of other factors;Minerva Medica;2022-02